The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó (born 1955) and Drew Weissman (born 1959) "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19".

This company, a division of BioNTech, commercialized mRNA vaccines at a global scale.

Drew Weissman was born on September 7, 1959, in Lexington, Massachusetts[6] and received a Ph.D. in 1987 at Boston University.

[7] He started studying RNA at the University of Pennsylvania in 1997,[8] where he met Karikó.

[9] The following publications were the fundamental researches that motivated the Nobel Assembly at Karolinska Institutet to award the 2023 Prize to Karikó and Weissman:[10]